Psychiatric Times

Efficacy Studies of Semaglutide for Type 2 Diabetes Mellitus

Pallavi Joshi, DO, MA, an assistant clinical professor in the University of Arizona College of Medicine – Phoenix's Department of Psychiatry, wrote about a meta-analysis of data from six placebo-controlled and seven active-controlled studies of the type 2 diabetes medication semaglutide. She discovered that when administered subcutaneously, it reduced blood sugar by 1.01% to 1.38%, depending on the dosage.


About the College

Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated more than 800 physicians, all of whom received exceptional training from nine clinical partners and more than 2,700 diverse faculty members. As the anchor to the Phoenix Bioscience Core, which is projected to have an economic impact of $3.1 billion by 2025, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.